Ault Alliance stockholders approve 1:300 reverse stock split; authorized share increase fails

Hyperscale Data, Inc.

Reverse stock split ratio of 1:300 approved; effective in Delaware May 17, 2023; shares reduced from 415.7M to ~1.39M.
Common stock trades split-adjusted on NYSE American from May 18, 2023 under new CUSIP 09175M408.
Proposal to increase authorized shares from 500M to 1B was not approved by stockholders.
No fractional shares issued; holders receive cash; Computershare is exchange agent.
Options, warrants, and similar instruments proportionally adjusted; par value remains $0.001 per share.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Hyperscale Data, Inc.: Amendment to Certificate of Incorporation to effect a one-for-three hundred reverse stock split of Class A common stock, reducing outstanding shares proportionally (effective 2023-05-17).

Change: charter amendment
Effective: 2023-05-17

Exact text from the filing

On May 15, 2023, pursuant to the approval provided by the stockholders of Ault Alliance, Inc. (the “ Company ”) at a special meeting of such stockholders of even date therewith (the “ Meeting ”), the Company’s Board of Directors approved an amendment to the Company’s Certificate of Incorporation (the “ Amendment ”) to effectuate a reverse stock split of the Company’s Class A common stock, $0.001 par value (“ Common Stock ”) affecting both the authorized and issued and outstanding number of such shares by a ratio of one-for-three hundred (the “ Reverse Stock Split ”).

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

Hyperscale Data, Inc. filing history →

Source: SEC EDGAR

accession 0001214659-23-007320

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.